Shenlian Biological (688098.SH) released the first three quarters of 2023 report, operating income of 239 million yuan, the same.
Zhitong Financial APP News, Shenlian Biological (688098.SH) released a report for the first three quarters of 2023, with operating income of 239 million yuan, down 16.46% from the same period last year. The net profit belonging to shareholders of listed companies was 37.1243 million yuan, down 48.70% from the same period last year. The net profit after deducting non-recurring gains and losses belonging to shareholders of listed companies was 29.6954 million yuan, down 53.79 percent from the same period last year. Basic earnings per share is 0.09 yuan.